Trade updates · Commerce

Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020

Published August 4, 2026 · effective July 31, 2026, 12:01 AM Eastern.

In TariffTrust's data

Integrated in the tariff Integrated in the USITC tariff, which now holds what it says. (2026 HTS Revision 21)

This notice revises the tariff rate on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom from 10 percent to zero percent in accordance with Proclamation 11020 "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States."

What it changes

Each measure as TariffTrust reads the official texts, each with its source. What a product owes depends on all the measures that apply to it: calculate it.

Official documents

The official text prevails. A publication alone does not establish applicability to a product.

A daily digest of the official actions that change US duties, and of what changed in our data.

Confirmation required; unsubscribe from any digest in one click.

Changelog All trade updates